Today Pfizer and BOD are delaying their penalty for 2 weeks without paying extra. They pretty much expect no one will bid more than 0.208, then after 2 weeks time yes vote will be over the line.
Behind this, Pfizer old us the 680k can be waived with a non exclusive license agreement upon clinical data. If RAP can fork out US clinical data within next 6 months (couple of million dollars were donated from Pfizer), RAP will be able to to injected with multiple million dollars only from non exclusive licenses, followed by cash positive business module.
The cost of materializing above is a few millions trial cost plus a successful NO result. CR has never been a problem, it’s only the faith in our heart to decide the future of this great OZ tech.
- Forums
- ASX - By Stock
- RAP
- Ann: Best and Final Confirmation and Bridging Loan
Ann: Best and Final Confirmation and Bridging Loan, page-97
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)